Within the MMR pathway, whose deficiency is commonly associated with CRC (Taieb et al. 2022), LIG1 and RFC3 were overexpressed in tumors, while POLD4 was upregulated in adjacent mucosa. The gene discussed is RFC3; the disease is colorectal carcinoma.